Advertisement

Topics

Breakthrough Gene Tool Attracts Investors Amid Patent Dispute

18:13 EDT 22 Sep 2016 | Wall Street Journal

Companies are seeking to capitalize on a hot new gene technology, though a high-stakes patent dispute has yet to be settled. The gene-editing tool, known as Crispr-Cas9, serves as a kind of multipurpose molecular scissors that can cut DNA.

Original Article: Breakthrough Gene Tool Attracts Investors Amid Patent Dispute

NEXT ARTICLE

More From BioPortfolio on "Breakthrough Gene Tool Attracts Investors Amid Patent Dispute"

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...